Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 yearsKIMBALL, A. B; GORDON, K. B; FAKHARZADEH, S et al.British journal of dermatology (1951). 2012, Vol 166, Num 4, pp 861-872, issn 0007-0963, 12 p.Article

Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-upPAPP, K. A; GRIFFITHS, C. E. M; STROBER, B et al.British journal of dermatology (1951). 2013, Vol 168, Num 4, pp 844-854, issn 0007-0963, 11 p.Article